PUBLISHER: TechNavio | PRODUCT CODE: 1184095
PUBLISHER: TechNavio | PRODUCT CODE: 1184095
Technavio has been monitoring the extracorporeal membrane oxygenation machines market and is forecast to grow by $243.6 million during 2022-2027, accelerating at a CAGR of 10.05% during the forecast period. Our report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of respiratory and heart failure, the rising number of new product launches, and the growing number of transplant procedures.
Technavio's extracorporeal membrane oxygenation machines market is segmented as below:
By Modality
By Product
By Geographical Landscape
This study identifies technological advances as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, positive results in respiratory failure diseases and treatment in infants will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the extracorporeal membrane oxygenation machines market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: